Formulary

9.1.6 Drugs used in neutropenia

First Line
Second Line
Specialist
Hospital Only
Zarzio

(Filgrastim)

  • Injection 30 million units (300 micrograms) in 0.5ml
  • Injection 48 million units (480 micrograms) in 0.5ml

Notes

  1. For use in North Devon District Hospital (Royal Devon University Healthcare NHS Foundation trust)
  2. Prescribe by brand. A biosimilar medicine is a biological medicine that is highly similar and clinically equivalent (in terms of quality, safety, and efficacy) to an existing biological medicine however they cannot be considered generic equivalents of the originator biological medicine. Because they are not identical, biological medicines must be prescribed by brand. The decision which brand to prescribe rests with the responsible clinician in consultation with the patient. Automatic substitution of brands at the point of dispensing is not appropriate for biological medicines.
Lenograstim
  • Pre-filled syringe 13.4 million-unit (105 micrograms), 33.6 million-unit (263 micrograms)

Notes

  1. For use in Royal Devon and Exeter Hospital (Royal Devon University Healthcare NHS Foundation Trust)
Pegfilgrastim
  • Pre-filled syringe 10mg/ml (0.6ml, 6mg pre-filled syringe)